January 30, 2018 /

Italfarmaco Provides Givinostat Update (January 2018)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Italfarmaco Provides Givinostat Update (January 2018)

Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo